About HospiraNews & MediaInvestor RelationsIn the CommunitySearch :  
Home
0

 
  • Precedex is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting.
  • Precedex should be administered by continuous infusion not to exceed 24 hours.
  • Caution should be exercised when administering Precedex to patients with advanced heart block and/or severe ventricular dysfunction.
Precedex is indicated for the sedation of initially intubated and mechanically ventilated patients and should be administered by continuous infusion not to exceed 24 hours.

Precedex is the only relatively selective alpha2-agonist approved for continuous intravenous (I.V.) sedation in the intensive care setting. It can be used before, during and after extubation.
 
This Web site and its information is intended for use by United States residents only. Countries outside the United States may have regulatory requirements, data requirements or medical practices that differ from the United States and, therefore, this information may be inappropriate for use outside the United States. Site contents are intended for informational purposes only and not intended to replace discussion with a healthcare provider. If you have any questions regarding this site, contact Hospira.
9-084